AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23880195
Drug: Pravastatin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin therapy for 2 years
Trial: 21071361
Drug: O+O (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: O+O (oral stimulation)
Trial: 17010806
Drug: Active therapy
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active therapy with elastic bandage of the legs (compression pressure 40 to 60 mm Hg) and abdomen (compression pressure 20 to 30 mm Hg) for 10 min each.
Trial: 17010806
Drug: Therapy with
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Therapy with elastic compression stockings of the legs (prescribed in all patients).
Trial: 9826312
Drug: Bosentan (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bosentan (1.0 g BID)
Trial: 1084825
Drug: Sulindac 240
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulindac 240 mg
Trial: 1084825
Drug: Sulindac 400
RxNorm normalized name: Sulindac
DrugBank: Sulindac (DB00605)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sulindac 400 mg
Trial: 1084825
Drug: Aspirin 4.8
RxNorm normalized name: oxycodone HCl/aspirin 4.8355 mg-325 mg ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 4.8 gm
Trial: 31222344
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose Mo and Cd co-treated group
Trial: 31222344
Drug: Combination groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination groups (Mo and Cd co-exposure)
Trial: 21555773
Drug: 20 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 µg of teriparatide once daily for 28 days
Trial: 19555809
Drug: L-arginine (1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (1.5 g bid)
Trial: 19555809
Drug: Simvastatin (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (20 mg qd) with L-arginine
Trial: 17200474
Drug: Pexelizumab (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pexelizumab (2 mg/kg intravenous bolus prior to PCI followed by 0.05 mg/kg per hour infusion over 24 hours)
Trial: 11453960
Drug: Low-dose hydrocortisone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose hydrocortisone (5 or 10 mg)
Trial: 7912766
Drug: Virosome influenza
RxNorm normalized name: INFLUENZA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Virosome influenza vaccine
Trial: 7912766
Drug: Commercial whole-virus
RxNorm normalized name: INFLUENZA A VIRUS WHOLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Commercial whole-virus vaccine
Trial: 2073959
Drug: Krill enzyme
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Krill enzyme treatment
Trial: 2073959
Drug: Non-enzymatic treatment
RxNorm normalized name: hydrolyzed sericin (enzymatic; 2500 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-enzymatic treatment
Trial: 781227
Drug: Fenoprofen (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoprofen (400 mg Q6H)
Trial: 781227
Drug: Aspirin (1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (1,000 mg Q6H)
Trial: 31562758
Drug: Maintenance olaparib
RxNorm normalized name: Olaparib
DrugBank: Olaparib (DB09074)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Maintenance olaparib (300 mg b.i.d.; tablets)
Trial: 28558366
Drug: Antidepressant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant treatment in MDD patients with AIHM
Trial: 26091286
Drug: BR-TD-1001 (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BR-TD-1001 (test vaccine)
Trial: 19449015
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical therapy for slow-transit constipation
Trial: 16413699
Drug: Preradiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preradiotherapy treatment
Trial: 16413699
Drug: Postradiotherapy treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postradiotherapy treatment
Trial: 16413699
Drug: Patients with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients with major deviations in treatment schedule
Trial: 16413699
Drug: Patients without
RxNorm normalized name: patent blue violet
DrugBank: Patent Blue (DB13967)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients without major deviations in treatment schedule
Trial: 16608381
Drug: Intravenous propionyl
RxNorm normalized name: 3-Propionyl-10-dimethylaminoisopropylphenothiazine
DrugBank: Propiomazine (DB00777)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous propionyl L‐carnitine 600 mg 3 times weekly for 12 months
Trial: 7734254
Drug: Hyperbaric amethocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperbaric amethocaine 8 mg
Trial: 2271747
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg SR tablets after a high fat breakfast
Trial: 2271747
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg SR tablets in fasted state
Trial: 2271747
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg SR tablets 1 h before, 0.5 h after, 2 h after a high fat meal
Trial: 31182442
Drug: Prescription support-tool
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription support-tool
Trial: 31182442
Drug: No prescription
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No prescription support-tool (Control)
Trial: 23599316
Drug: RRV-TV (tetravalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RRV-TV (tetravalent rotavirus vaccine)
Trial: 19660042
Drug: Abstinence with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abstinence with transdermal nicotine patch
Trial: 14756910
Drug: Cream (CREAM)
RxNorm normalized name: Oral Cream
DrugBank: Coffea arabica seed, roasted (DB15603)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cream (CREAM)
Trial: 3795326
Drug: Continuous therapy
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuous therapy with mebendazole (1800 mg day-1 for 18 weeks)
Trial: 3795326
Drug: Interrupted therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interrupted therapy with mebendazole (1800 mg day-1 for interrupted 6-week courses for a minimum of three courses, with intervals of 19-22 weeks)
Trial: 29648532
Drug: Fixed-dose combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-dose combination (FDC) tablet of repaglinide/metformin (2/500 mg)
Trial: 29648532
Drug: Equivalent doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Equivalent doses of individual (EDI) tablets of repaglinide (2 mg) and metformin (500 mg)
Trial: 26431653
Drug: Chinese drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chinese drug iontophoresis
Trial: 21477901
Drug: Sterol fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterol fortified orange juice (1g/240 ml juice twice a day)
Trial: 21477901
Drug: Sterol fortified
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterol fortified OJBev (1g/240 ml beverage twice a day)
Trial: 15614460
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg ivermectin (110 microg/kg) administered as a single dose, repeated 2 weeks later
Trial: 15614460
Drug: 200 microg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 microg/kg ivermectin administered as a single dose, repeated 2 weeks later
Trial: 12032393
Drug: Subcutaneous administration
RxNorm normalized name: subcutaneous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous administration of 8000 anti-FXa units LMWH Certoparin
Trial: 12032393
Drug: Intravenous administration
RxNorm normalized name: intravenous administration set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous administration of 8000 anti-FXa units LMWH Certoparin
Trial: 785948
Drug: Haloperidol administered
RxNorm normalized name: Haloperidol
DrugBank: Haloperidol (DB00502)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Haloperidol administered for 16 weeks
Trial: 30611454
Drug: PFMT plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PFMT plus solifenacin (5 mg/d over 36 weeks)
Trial: 27282116
Drug: Oral vitamin
RxNorm normalized name: vitamin A Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vitamin D3 (2000μg)
Trial: 22616628
Drug: GSK679586 (0.005,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK679586 (0.005, 0.05, 0.5, 2.5, 10 mg kg(‐1))
Trial: 22616628
Drug: GSK679586 (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GSK679586 (2.5, 10, 20 mg kg(‐1))
Trial: 21818506
Drug: SRD174 cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SRD174 cream
Trial: 6431795
Drug: sublingual isosorbide
RxNorm normalized name: isosorbide dinitrate Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual isosorbide dinitrate (ISDN)
Trial: 26799892
Drug: Smartphone-based intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smartphone-based intervention program including one Skype session and six weeks of daily directive text messages guiding app use.
Trial: 22077909
Drug: Abciximab plus
RxNorm normalized name: Abciximab
DrugBank: Abciximab (DB00054)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Abciximab plus unfractionated heparin
Trial: 18754096
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole 40 mg every 24 h
Trial: 18754096
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole 40 mg every 12 h (q12h)
Trial: 18754096
Drug: Intravenous pantoprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous pantoprazole 80 mg q12h
Trial: 10707752
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose captopril (50 mg b.i.d.)
Trial: 10707752
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose captopril (25 mg b.i.d.)
Trial: 1357516
Drug: Guaifenesin (2400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guaifenesin (2400 mg daily for 3 weeks)
Trial: 3907494
Drug: Oxacillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin plus rifampin (12 g/day, intravenously; rifampin 1,200 mg/day, orally)
Trial: 3907494
Drug: Oxacillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin plus placebo (12 g/day, intravenously)
Trial: 2439344
Drug: Cisplatin-containing regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisplatin-containing regimen (methotrexate 30 mg/m2, bleomycin 15 mg, hydroxyurea 1000 mg/m2, cisplatin 60 mg/m2)
Trial: 2439344
Drug: 3-drug combination
RxNorm normalized name: miconazole
DrugBank: Miconazole (DB01110)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-drug combination (methotrexate 30 mg/m2, bleomycin 15 mg, hydroxyurea 1000 mg/m2)
Trial: 29389467
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of massage and warm-up
Trial: 21112549
Drug: Radachlorin® solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radachlorin® solution for intravenous infusions 0.35% 10mL at doses of 0.5‐0.6 and 1.0‐1.2mg/kg
Trial: 21112549
Drug: Radachlorin® gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radachlorin® gel for topical application 0.1% 25g at a dose of 0.1g/cm(2)
Trial: 21112549
Drug: Drug administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Drug administration at a dose of 1.0‐1.2mg/kg and irradiation at 3h with 662±3nm light at a dose of 300J/cm(2) (solution)
Trial: 21112549
Drug: 4 PDT
RxNorm normalized name: Porfimer sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 PDT sessions at an interval of 1 week with 3h gel exposure, followed by 400J/cm(2) light exposure (gel)
Trial: 11003362
Drug: EOS-guided steroid
RxNorm normalized name: EO-3021
DrugBank: EO-3021 (DB18358)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EOS-guided steroid dose adjustment (RG)
Trial: 14607663
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg buscopan
Trial: 1523144
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg papaverine
Trial: 1523144
Drug: 2 ml
RxNorm normalized name: ethanol 2 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 ml of 0.9% NaCl solution
Trial: 30666153
Drug: BP-C1 (0.035
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BP-C1 (0.035 mg/kg bodyweight, daily intramuscular injection for 32 days)
Trial: 27634487
Drug: Sodium bicarbonate
RxNorm normalized name: Sodium Bicarbonate
DrugBank: Sodium bicarbonate (DB01390)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sodium bicarbonate (0.3 g kg-1)
Trial: 24828266
Drug: Minitab sprinkles
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minitab sprinkles (40 mg/10 mg)
Trial: 18558645
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (n=21)
Trial: 16858935
Drug: Roselle flower
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roselle flower tea (RFT) administered at 4,000 mg in 480 ml of hot distilled water
Trial: 11824237
Drug: Endoscopic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic therapy (thermal, mechanical, and injection procedures)
Trial: 3134556
Drug: Oxamniquine 60
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxamniquine 60 mg/kg
Trial: 2514474
Drug: Oxamniquine 40
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxamniquine 40 mg/kg
Trial: 3134556
Drug: Oxamniquine 20
RxNorm normalized name: oxamniquine
DrugBank: Oxamniquine (DB01096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxamniquine 20 mg/kg
Trial: 1935730
Drug: Oxamniquine (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxamniquine (all doses)
Trial: 26468074
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl 25 μg
Trial: 8712444
Drug: Epidural meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural meperidine 25 mg
Trial: 26468074
Drug: Epidural clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epidural clonidine 2 μg/kg
Trial: 24529670
Drug: Ketamine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine infusion (0.1 mg/kg/hour)
Trial: 21377295
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol 400 μg
Trial: 19694865
Drug: Intervention toolkit
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intervention toolkit including admission form with geriatric cues, facsimile to the primary care provider, interdisciplinary worksheet, pharmacist-physician collaborative medication reconciliation, predischarge planning appointments.
Trial: 15254060
Drug: Gabapentin (600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (600 mg/d to 1,800 mg/d)
Trial: 11229465
Drug: Intraarticular glucocorticoid
RxNorm normalized name: dexamethasone
DrugBank: Dexamethasone acetate (DB14649)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intraarticular glucocorticoid treatment (120 mg of methylprednisolone acetate)
Trial: 9751468
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg methylprednisolone in mepivacaine 0.25%
Trial: 7908257
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg SL 84.0418
Trial: 7908257
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg SL 84.0418
Trial: 7908257
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg SL 84.0418
Trial: 3391881
Drug: Erythromycin base
RxNorm normalized name: Erythromycin base
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin base (EB) 500 mg tid
Trial: 3391876
Drug: Erythromycin acistrate
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin acistrate (EA) 500 mg tid
Trial: 25624132
Drug: 200 μg/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 μg/d of nasal fluticasone propionate
Trial: 23826101
Drug: Epirubicin 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin 75 mg/m2 and docetaxel 75 mg/m2 (Epi/Doc)
Trial: 19433683
Drug: Pemetrexed 500
RxNorm normalized name: pemetrexed 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pemetrexed 500 mg/m² plus carboplatin AUC = 5 on day 1
Trial: 19433683
Drug: Gemcitabine 1,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine 1,000 mg/m² on days 1 and 8 plus carboplatin AUC = 5 on day 1
Trial: 16969059
Drug: Primaquine 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Primaquine 30 mg once daily for 7 days (group A, n = 71)
Trial: 16969059
Drug: Elubaquine 25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elubaquine 25 mg once daily for 7 days (group B, n = 70)
Trial: 15590356
Drug: Enalaprilat infusion
RxNorm normalized name: Enalaprilat
DrugBank: Enalaprilat (DB09477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Enalaprilat infusion (0.06 mg/kg/hr) during CPB
Trial: 15590356
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (dopamine infusion only)
Trial: 11704167
Drug: 49-day cycle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 49-day cycle (42 active pills)
Trial: 11704167
Drug: 28-day cycle
RxNorm normalized name: norgestimate
DrugBank: Norgestimate (DB00957)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 28-day cycle (21 active pills)
Trial: 478062
Drug: Sterosan-hydrocortison ointment
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Sterosan-hydrocortison ointment
Trial: 478062
Drug: Sterosan ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterosan ointment
Trial: 478062
Drug: Sterosan cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterosan cream
Trial: 478062
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of chlorquinaldol
Trial: 25705958
Drug: Propoxyphene/Acetaminophen (PA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propoxyphene/Acetaminophen (PA)
Trial: 22182419
Drug: Behavioral treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral treatments for adolescent marijuana abuse or dependence
Trial: 17948223
Drug: Surgery followed
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Surgery followed by uracil-tegafur 360 mg/m²/day for 16 months
Trial: 11867823
Drug: Azithromycin (AZM)
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin (AZM) 250 mg/day
Trial: 6222086
Drug: Oral 13-cis-retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 13-cis-retinoic acid at 0.1 mg/kg/day
Trial: 6222086
Drug: Oral 13-cis-retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 13-cis-retinoic acid at 0.5 mg/kg/day
Trial: 6222086
Drug: Oral 13-cis-retinoic
RxNorm normalized name: 13-cis-retinoic acid
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral 13-cis-retinoic acid at 1.0 mg/kg/day
Trial: 6222086
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of oral 13-cis-retinoic acid
Trial: 6222086
Drug: Clinical response
RxNorm normalized name: DuoCare Clinical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clinical response to treatment
Trial: 26914224
Drug: Etomidate 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.15 mg/kg
Trial: 26914224
Drug: Etomidate 0.15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etomidate 0.15 mg/kg with hydrocortisone
Trial: 22249601
Drug: Contrast-enhanced ultrasound
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast-enhanced ultrasound with perflutren contrast agent
Trial: 15196302
Drug: 1.2 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.2 mg/kg intravenous LY293558
Trial: 14578014
Drug: Flumazenil (FLU)
RxNorm normalized name: Flumazenil
DrugBank: Flumazenil (DB01205)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flumazenil (FLU) 1 mg twice a day for 8 days
Trial: 14578014
Drug: Oxazepam tapering
RxNorm normalized name: Oxazepam
DrugBank: Oxazepam acetate (DB14672)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxazepam tapering (from 120 mg)